← FDA Drug Approvals (Drugs@FDA)

YESAFILI

BLA · Biologics License Application · Sponsor: BIOCON BIOLOGICS INC · Approved 2024-05-20

Drug application

FDA Application #

BLA761274

Application type

Biologics License Application

Brand name

YESAFILI

Generic name

Aflibercept-Jbvf

Active ingredients

AFLIBERCEPT-JBVF

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

BIOCON BIOLOGICS INC

First approval

2024-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown